Stratec SE
XETRA:SBS
Relative Value
The Relative Value of one
SBS
stock under the Base Case scenario is
hidden
EUR.
Compared to the current market price of 21.35 EUR,
Stratec SE
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
SBS Competitors Multiples
Stratec SE Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| DE |
|
Stratec SE
XETRA:SBS
|
255.9m EUR | 1 | 16.6 | 7.5 | 12.5 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192B USD | 4.3 | 29.4 | 16.7 | 22.7 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
174.6B USD | 17.3 | 61.1 | 46.6 | 56.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
136.5B USD | 5.4 | 42.1 | 21.4 | 25.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
131.8B USD | 3.8 | 27.7 | 15.5 | 22.4 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
112.1B USD | 5.8 | 40.2 | 23.9 | 32.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.8B USD | 2.7 | 35.6 | 13 | 22.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46.1B EUR | 2 | 21.7 | 12 | 16.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
51.6B USD | 12 | 48.7 | 34.8 | 38.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
45.4B USD | 7.7 | 33.2 | 23.6 | 25.8 | |
| US |
|
Resmed Inc
NYSE:RMD
|
39.5B USD | 7.3 | 26.6 | 18.8 | 20.9 |